Who Are We?
The Center for Advanced Functional Neuroimaging (CAFN), directed by Greg Zaharchuk, MD, PhD and Michael Moseley, PhD, is part of Radiological Sciences Lab in the Department of Radiology at Stanford University's School of Medicine. We develop novel Magnetic Resonance Imaging (MRI) techniques to better understand human brain functions, delineate brain structures, and diagnose brain diseases.
CAFN is built upon a large framework of funded NIH grants from the Radiological Sciences Laboratory (RSL), Lucas Center for Imaging, and Stanford Stroke Center faculty dedicated to bringing the best MRI techniques to everyday clinical use.
We drive key clinical areas of neuroimaging focusing on disease processes in stroke, brain tumors, and other cerebrovascular diseases using tissue perfusion mapping (PWI), diffusion MRI (DWI)
We drive key clinical areas of neuroimaging focusing on disease processes in stroke, brain tumors, and other cerebrovascular diseases using tissue perfusion mapping (PWI), diffusion MRI (DWI), as well as new fields of mapping the brain connectivity: diffusion tensor imaging (DTI), susceptibility-weighted MRI (SWI), and Quantitative Susceptibility Mapping (QSM). CAFN also develops and uses high-resolution quantitative diffusion tensors and perfusion maps to explore and map complex brain structure and function in active mental tasking, revealing new key findings in the developing and aging brain function for blood flow, tissue integrity, and cognition.
CAFN collaborates with researchers from the Stanford Stroke Center, Departments of Neurology, Neurosurgery, Psychiatry and Psychology, Duke University, Lucille Packard Children’s Hospital, Palo Alto VA Medical Center and other research institutions to discover new ways of approaching the brain’s most complex problems.
Michael Moseley named as ARR Distinguished Investigator
August 2015 Dr. Michael Moseley was recently named as a Distinguished Investigator of the Academy of Radiology Research.